Effectiveness of Hydrogen Water Intervention on Acute Oral Inflammation, Oral Microbiota, and Pain Following Free Flap Reconstruction in Patients With Oral Cancer

This randomized, double-blind, parallel-group controlled trial evaluates the effectiveness of hydrogen water oral care on acute oral inflammation, oral microbiota, and pain in patients with oral cancer who have undergone free flap reconstruction. After postoperative transfer from the intensive care unit to the plastic surgery ward, eligible patients who provide written informed consent are randomly assigned in a 1:1 ratio to receive oral care with either hydrogen water or boiled drinking water for 7 days. Saliva samples and pain assessments are collected at baseline (T0), Day 3 (T1), and Day 7

Trial Details

NCT ID
NCT07306546
Phase
NA
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Status
RECRUITING
Cancer Type
Salivary Gland Head and Neck Cancer
Interventions
  • Hydrogen Water Oral Care
  • Water Oral Care
Locations (sample)
  • Kaohsiung City, Taiwan|22.61626,120.31333

Key Eligibility Criteria

  • Diagnosed with oral cancer and undergoing microsurgical flap reconstruction.
  • Age 18 years or older.
  • Clear consciousness.
  • Able to communicate without difficulty in Mandarin, Taiwanese, or in writing.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Salivary Gland Head and Neck Cancer Trials on Trialify →